Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DELRAY BEACH, Fla., May 12, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, announced today...
-
COVID-19 drastically affects imaging center scan volumes and delays installations of two MRI scanners until 1st Quarter of Fiscal 2021. Upon their completion, FONAR subsidiary, HMCA, will...
-
First Quarter 2020 Highlights Net sales increased 5.1 percent to $95.9 million from $91.3 million in 2019GAAP net income was $3.0 million compared to $1.7 million in the prior yearGAAP net income per...
-
Funds clinical development of NVX-CoV2373 through Phase 2Supports rapid scale-up of vaccine manufacturingAllows for increased production of Matrix-M adjuvantReserves global large-scale manufacturing...
-
GAITHERSBURG, Md., May 11, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
-
AUSTIN, Texas, May 11, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. and Mitesco, Inc. (OTC QB: MITI) (the “Company” or “Mitesco”) announced today that a new interview with Larry Diamond and...
-
NEWTOWN, Pa., May 11, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
-
SALT LAKE CITY, May 11, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food and Drug...
-
TEL-AVIV, Israel and RALEIGH, N.C., May 11, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that...
-
VANCOUVER, Washington, May 11, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5...